Olivia C Ware
CIK 1663771 · Chief Commercial Officer · last filed 2026-04-28
Olivia C Ware is a Chief Commercial Officer who has filed 17 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for ACLX, was dated Apr 28, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
17
-$1.16M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. (ACLX) Delisted | Director | 9,402 | $115.07 | $1.08M | -$1.16M | 7 | 2026-04-28 |
| CTNM | Director | — | $11.88 | — | $0 | 2 | 2025-06-26 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 0 | $3.65 | $0 | $0 | 7 | 2025-02-06 |
| LadRx Corp (CYTXW) Delisted | Chief Commercial Officer | — | — | — | $0 | 1 | 2016-01-14 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-28 | Arcellx, Inc. (ACLX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-26 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Mixed | −31,675 | -$60.9K | EDGAR |
| 2024-06-06 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2024-05-03 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2024-04-18 | Arcellx, Inc. (ACLX) Delisted | Mixed | — | -$450.7K | EDGAR |
| 2024-03-18 | Arcellx, Inc. (ACLX) Delisted | Mixed | — | -$565.1K | EDGAR |
| 2023-06-16 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |